Page last updated: 2024-11-05

zonisamide and Granulocytic Leukemia

zonisamide has been researched along with Granulocytic Leukemia in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Valproic acid is an effective anti-epileptic medication often used for long-term control of seizure disorders that has been implicated in hematological toxicities, including rare reports of myelodysplasia and acute leukemia."1.35Translocation-positive acute myeloid leukemia associated with valproic acid therapy. ( Ben-Ezra, J; Massey, GV; Riley, RS; Russell, EC; Williams, DC, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, DC1
Massey, GV1
Russell, EC1
Riley, RS1
Ben-Ezra, J1

Other Studies

1 other study available for zonisamide and Granulocytic Leukemia

ArticleYear
Translocation-positive acute myeloid leukemia associated with valproic acid therapy.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Acute Disease; Anticonvulsants; Cell Differentiation; Cell Division; Child, Preschool; Chromosomes,

2008